Held February 25 in Winston-Salem, the Triad’s largest annual charitable fundraiser honored Novant Health President and CEO Carl Armato
Beverly Berry Living and Giving Award presented to Mike Conrad, former Chapter Executive Director
Greensboro, North Carolina, March 2, 2017 – JDRF’s Piedmont Triad Chapter announced today that its 17th annual Hope Gala raised over $1.2 million to cure, prevent, and treat type 1 diabetes (T1D). This marks the sixth time since 2011 that the Gala has raised at least $1 million.
Chaired this year by Wendy and Brad Calloway, the Gala alternates between Winston-Salem and Greensboro. On Saturday, February 25, nearly 1,000 people attended the 2017 event at the Benton Convention Center in Winston-Salem.
Novant Health President and CEO Carl Armato, who was diagnosed with T1D when he was 18 months old, was honored at the Gala, receiving a medal in recognition of living with the disease for more than 50 years. Armato’s remarks, “The Power of YES,” in which he recounted his own personal T1D journey, moved many in the audience to tears. In closing, Armato said:
“Without the funding JDRF provides for research and education, there is no doubt my life would look very different today.
“That’s not just true for me; it’s true for the approximately 1.3 million Americans living with T1D, many of whom feel their lives—their ambitions—are obstructed every single day by the ‘no’ that diabetes delivers. I know firsthand that the physical and emotional challenges of this disease are extremely real. And that’s why I’m excited by JDRF’s goal—to turn Type One into ‘Type None.’”
Armato’s remarks introduced the Fund A Cure segment of the evening, when guests make donations (of $100 to $50,000) that directly fund T1D research. JDRF’s Piedmont Triad Chapter Board President Brad Hayes said, “By articulating so eloquently what it’s like to grow up with—and succeed in spite of—T1D, Carl painted a realistic yet hopeful picture. He explained why supporting JDRF in its journey to ‘turn Type One into Type None’ is so important. And he moved hundreds of people to increase their level of support to JDRF. We are very grateful to Carl for sharing his story.”
Former Piedmont Triad Chapter Executive Director Mike Conrad, who retired in October 2016, received the Beverly Berry Living and Giving Award. Named for the late Beverly Berry, who had T1D and co-founded The Fresh Market with her husband Ray, this is the Chapter’s highest award. Longtime Chapter supporter Sam Hummel presented the award to Conrad, saying that Mike is “the most beloved and most deserving person in our Chapter, the man who led us with boundless enthusiasm and hard work for the past 16 years.”
Led by Presenting Sponsors BB&T, LabCorp, and Novant Health, the corporate community rallied in support of the Hope Gala and T1D research, with corporate sponsorships ranging from $3,000 to $50,000 for a total of approximately $500,000. The balance of the $1.2 million raised came from individual ticket and table sales, silent and live auctions, a raffle, wine pull, and Fund A Cure donations.
Shamrock Environmental Corporation challenged attendees to make $1,000 Fund A Cure gifts by providing a dollar-for-dollar match. Similarly, all Fund A Cure donations at the $100 to $500 levels were matched dollar-for-dollar by a consortium of supporters including Wendy and Brad Calloway, Anne and Sam Hummel, Lynn and Winton Jennette, Beth and Brice O’Brien, and Mark Peters.
Individuals may continue to make donations in honor of Carl Armato or another individual living with T1D by calling the JDRF Piedmont Triad Chapter office at (336) 373-1768.
About Type 1 Diabetes: Type 1 diabetes (T1D) is an autoimmune disease that impacts millions of people around the world. The disease occurs when the body’s immune system attacks and destroys the beta cells in the pancreas that produce insulin, a hormone essential to turning food into energy. Without insulin, glucose from food stays in the blood, where it can cause serious damage to all of the body’s organ systems. It requires constant carbohydrate counting, blood-glucose testing, and lifelong dependence on injected insulin. With T1D there are no days off, and there is no cure.
About JDRF: JDRF is the leading global organization focused on type 1 diabetes (T1D) research, and has committed over $2 billion to research since its founding in 1970. JDRF and its supporters share the vision of “a world without type 1 diabetes,” and work every day to support the organization’s mission of “accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications.” JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to bring life-changing therapies from the lab to the community. As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in charitable research in 18 countries—including 50 active clinical trials. jdrf.org
2017 Hope Gala Sponsors: JDRF thanks our sponsors, many of whom have supported T1D research for years. Major 2017 sponsors include:
- Novant Health
- The Fresh Market
- McKinsey & Company
- McMichael Foundation
- Wake Forest Baptist Health
- Wells Fargo
- Paul Fulton
- Lilly Diabetes
- Bobby Long
- Ralph Lauren
- Reynolds American
- Rodgers Builders
- Sara Smith Self Foundation
- Arch MI
- Bank of America
- Brasfield and Gorrie
- Elon University
- Ernst & Young
- Krispy Kreme
- Providence Anesthesiology Associates
- Shelco Construction
- Tom Davis Fund
- Wyndham Championship
- XPO Logistics